{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":32,"n_cols":5,"rows_kept":32,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[12,2,12,3],[13,2,13,3],[15,2,15,3],[15,4,15,5],[16,2,16,3],[16,4,16,5],[17,2,17,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[22,2,22,3],[24,2,24,3],[25,2,25,3],[29,2,29,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA990004010280403321"]
[null,null,"Autore",null,"Orelli, Giorgio <1921- >"]
[null,null,"Titolo",null,"Accertamenti montaliani / Giorgio Orelli"]
[null,null,"Pubbl/distr/stampa",null,"Bologna : il Mulino, 1984"]
[null,null,"ISBN",null,"88-15-00642-7"]
[null,null,"Descrizione fisica",null,"140 p. ; 21 cm"]
[null,null,"Collana",null,"Saggi ; 279"]
[null,null,"Disciplina",null,"851.912"]
[null,null,"Locazione",null,"FLFBC"]
[{"$nulls":4},"BAT"]
[null,null,"Collocazione",null,"851.912 MONT/S 27"]
[{"$nulls":4},"F.Russo 956"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910961988003321"]
[null,null,"Titolo",null,"Addressing methamphetamine abuse / / Nathan B. Talcote, editor"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Science Publishers, c2009"]
[null,null,"ISBN",null,"1-61728-124-7"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (105 p.)"]
[null,null,"Disciplina",null,"362.29/950973"]
[null,null,"Soggetti",null,"Methamphetamine abuse - United States"]
[{"$nulls":4},"Methamphetamine - United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, Second Sesssion, June 28, 2006\"--P. 1."]
[{"$nulls":4},"Includes index."]
[null,null,"Nota di contenuto",null,"Intro -- ADDRESSING METHAMPHETAMINE ABUSE -- ADDRESSING METHAMPHETAMINE ABUSE -- CONTENTS -- PREFACE -- HEARING BEFORE THE SUBCOMMITTEE ON CRIMINAL JUSTICE, DRUG POLICY, AND HUMAN RESOURCES  OF THE COMMITTEE ON GOVERNMENT REFORM HOUSE OF REPRESENTATIVES ONE HUNDRED NINTH CONGRESS SECOND SESSION JUNE 28, 2006 -- METHAMPHETAMINE TREATMENT:  AVAILABILITY AND EFFECTIVENESS OF PROGRAMS TO TREAT VICTIMS OF THE METHAMPHETAMINE EPIDEMIC -- STATEMENTS OF BERTHA MADRAS,  DEPUTY DIRECTOR, OFFICE OF DEMAND REDUCTION, OFFICE OF NATIONAL DRUG CONTROL POLICY -- NORA D. VOLKOW, M.D., DIRECTOR, NATIONAL INSTITUTE ON DRUG ABUSE, NATIONAL INSTITUTES OF HEALTH, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES -- AND CHARLES G. CURIE, M.A., A.C.S.W., ADMINISTRATOR, SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, ACCOMPANIED BY H. WESTLEY CLARK, M.D., J.D., M.P.H., CAS, FASAM, DIRECTOR, CENTER F -- STATEMENT OF BERTHA MADRAS -- STATEMENT OF NORA D. VOLKOW, M.D. -- STATEMENT OF CHARLES G. CURIE -- STATEMENTS OF RUSSELL CRONKHITE, RECOVERED METH ADDICT -- DARREN AND AARONETTE NOBLE, RECOVERED METH ADDICTS, ACCOMPANIED BY JOSEPH BINKLEY -- RICHARD A. RAWSON, PH.D,  ASSOCIATED DIRECTOR, INTEGRATED SUBSTANCE ABUSE PROGRAMS, "]
[{"$nulls":4},"UCLA -- LEAH C. HEASTON, MSW, LCSW, ACSW, SAP, NOBLE COUNTY DIRECTOR,  OTIS R. BOWEN, CENTER FOR HUMAN SERVICES, INC. -- MICHAEL B. HARLE, MHS, GAUDENZIA, INC. -- AND PAT FLEMING, DIRECTOR, SALT LAKE COUNTY SUBSTANCE ABUSE SERVICES -- STATEMENT OF RUSSELL CRONKHITE -- STATEMENT OF DARREN NOBLE -- STATEMENT OF AARONETTE NOBLE -- STATEMENT OF JOSEPH BINKLEY -- STATEMENT OF RICHARD A. RAWSON, PH.D -- STATEMENT OF LEAH C. HEASTON -- STATEMENT OF MICHAEL B. HARLE -- STATEMENT OF PAT FLEMING -- INDEX -- Blank Page."]
[null,null,null,"Sommario/riassunto","The meth epidemic has touched every State in the country, draining resources, causing serious environmental damage and destroying lives. SAMHSA's Drug Abuse Warning Network DAWN], showed that in the early to mid-1990's, methamphetamine use was on the rise. The treatment episode data confirmed this: treatment admissions for meth use grew through the 1990's, increasing fivefold between 1992 and 2002. The most recent treatment episode data show that 15 States have higher rates of admission for amphetamine use, largely meth, than for heroin or cocaine. In just those 15 States, there were over 102,000 admissions for amphetamine treatment, versus 73,000 combined admissions for heroin and cocaine. Nationwide, there were more than 151,000 admissions for amphetamine treatment. To say that meth is highly addictive is an understatement, and it presents unique clinical challenges for treatment. Meth produces a short, intense rush, followed by a long-lasting sense of euphoria. Addiction to meth is caused by the way the drug alters the brain and leaves the users to compulsively seek more meth. Chronic use of the drug also leads to increased tolerance, prompting the user to take higher or more frequent doses of the drug to get the same effect. Moreover, meth users may also develop severe psychotic and paranoid behavior. Meth users who do seek treatment often relapse and continue chronic meth use. There are currently no medications that demonstrate effectiveness in treating meth addiction. But intense behavioral interventions have proven effective. The largest controlled study of meth treatment conducted by the Center for Substance Abuse Treatment demonstrated positive post-treatment outcomes for 60 percent of the treatment sample, which reported no meth use and which had urine samples that tested negative for meth. Nonetheless, traditional treatment programs for alcohol and marijuana are inadequate for dealing with the unique clinical challenge"]